Guerra B, Guida G, Falco P, Gabrielli S, Martinelli G N, Bovicelli L
II Department of Obstetrics and Gynecology, Bologna University School of Medicine, Italy.
Obstet Gynecol. 1996 Jul;88(1):77-81. doi: 10.1016/0029-7844(96)00109-3.
To evaluate whether microcolposcopic topographic endocervical assessment reduces the failures of excisional treatment of cervical intraepithelial neoplasia (CIN).
Three hundred fifty patients with colposcopic and histopathologic findings of endocervical CIN were recruited for excisional treatment. Three hundred forty-eight of these were randomized to have or not have microcolposcopy before excisional treatment. Measurement of endocervical lesion was the only aim of microcolposcopic evaluation. When an endocervical extension was available, the cone biopsy was cut according to microcolposcopic measurement. Excision status was evaluated and related to presurgical management on operative specimens. After excision, patients were followed-up for at least 5 years after treatment. Three hundred thirty (171 and 159 with and without preoperative microcolposcopy, respectively) patients completed the study. Disease persistences were defined by cytologic, colposcopic, and histologic results. Microcolposcopic value was defined as completeness of excision and/or lack of persistent disease. RESULTS. On surgical specimens, involved margins were detected in 19 (5.4%) cases. Presurgical microcolposcopy was performed in only one of these cases. The difference of incomplete excision between cases with or without microcolposcopy was statistically significant (P < .001). In patients who were followed-up, persistent disease was detected in one (0.6%) woman in the microcolposcopy group and in 16 (10%) women in the control group. Comparison between the two groups showed a significantly lower risk of persistent disease when presurgical microcolposcopy was performed (P < .001).
By measuring endocervical extension of the lesion, preoperative microcolposcopy allows individualized cones, thus improving the prognosis after excisional treatment of CIN.
评估显微阴道镜下宫颈管内病变的地形学评估是否能减少宫颈上皮内瘤变(CIN)切除治疗的失败率。
招募350例经阴道镜及组织病理学检查确诊为宫颈管内CIN的患者进行切除治疗。其中348例患者被随机分为两组,一组在切除治疗前接受显微阴道镜检查,另一组不接受。显微阴道镜评估的唯一目的是测量宫颈管内病变。当存在宫颈管内病变延伸时,根据显微阴道镜测量结果进行锥形活检。对手术标本的切除状态进行评估,并与术前处理相关联。切除术后,对患者进行至少5年的随访。330例患者(分别有171例和159例接受和未接受术前显微阴道镜检查)完成了研究。疾病持续存在由细胞学、阴道镜和组织学结果定义。显微阴道镜的价值定义为切除的完整性和/或无疾病持续存在。结果:在手术标本中,19例(5.4%)检测到切缘受累。其中只有1例进行了术前显微阴道镜检查。接受或未接受显微阴道镜检查的病例之间不完全切除的差异具有统计学意义(P <.001)。在接受随访的患者中,显微阴道镜检查组有1名女性(0.6%)检测到疾病持续存在,而对照组有16名女性(10%)。两组比较显示,进行术前显微阴道镜检查时疾病持续存在的风险显著降低(P <.001)。
通过测量病变的宫颈管内延伸,术前显微阴道镜检查可实现个体化锥形切除,从而改善CIN切除治疗后的预后。